| 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VASP mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | decreases phosphorylation | ISO | RGD:1311542 | 6480464 | Estradiol deficiency results in decreased phosphorylation of VASP protein | CTD | PMID:18787021 |
| 17beta-hydroxy-5alpha-androstan-3-one | multiple interactions | ISO | RGD:1323055 | 6480464 | [Dihydrotestosterone results in increased activity of AR protein mutant form] which results in increased phosphorylation of VASP protein | CTD | PMID:18819937 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | multiple interactions | ISO | RGD:1311542 | 6480464 | nebivolol inhibits the reaction [Phorbol Esters results in decreased phosphorylation of VASP protein]; more ... | CTD | PMID:16940222 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of VASP mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of VASP mRNA | CTD | PMID:21570461 |
| acetaldehyde | affects expression | EXP | | 6480464 | Acetaldehyde affects the expression of VASP mRNA | CTD | PMID:22634333 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1323055 | 6480464 | Tretinoin results in increased expression of VASP mRNA | CTD | PMID:15498508 |
| benomyl | multiple interactions | ISO | RGD:1311542 | 6480464 | Benomyl inhibits the reaction [Pentaerythritol Tetranitrate results in increased phosphorylation of VASP protein]; more ... | CTD | PMID:15331769 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of VASP mRNA | CTD | PMID:19770486 |
| cadmium atom | increases expression | ISO | RGD:1323055 | 6480464 | Cadmium results in increased expression of VASP mRNA | CTD | PMID:22562489 |
| carbamazepine | affects expression | EXP | | 6480464 | Carbamazepine affects the expression of VASP mRNA | CTD | PMID:22634333 |
| choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VASP gene | CTD | PMID:20938992 |
| chromium atom | multiple interactions | ISO | RGD:1311542 | 6480464 | Chromium inhibits the reaction [Sucrose results in decreased phosphorylation of VASP protein] | CTD | PMID:17215582 |
| cobalt dichloride | decreases expression | ISO | RGD:1323055 | 6480464 | cobaltous chloride results in decreased expression of VASP mRNA | CTD | PMID:19320972 |
| copper(2+) sulfate | increases expression | ISO | RGD:1323055 | 6480464 | Copper Sulfate results in increased expression of VASP mRNA | CTD | PMID:19549813 |
| curcumin | increases expression | ISO | RGD:1323055 | 6480464 | Curcumin results in increased expression of VASP mRNA | CTD | PMID:17198877 |
| cycloheximide | multiple interactions | EXP | | 6480464 | VASP mutant form promotes the reaction [[TNF co-treated with Cycloheximide] results in increased cleavage of SPNA2 protein]; more ... | CTD | PMID:18182247 |
| DDE | multiple interactions | ISO | RGD:1323055 | 6480464 | [Dichlorodiphenyl Dichloroethylene results in increased activity of AR protein mutant form] which results in increased phosphorylation of VASP protein | CTD | PMID:18819937 |
| dexamethasone | decreases expression | ISO | RGD:1311542 | 6480464 | Dexamethasone results in decreased expression of VASP mRNA | CTD | PMID:20032058 |
| dexamethasone | multiple interactions | ISO | RGD:1311542 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of VASP mRNA] | CTD | PMID:20032058 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of VASP mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of VASP mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:1311542 | 6480464 | Dibutyl Phthalate results in increased expression of VASP mRNA | CTD | PMID:21266533 |
| dioxygen | affects localization | EXP | | 6480464 | Oxygen deficiency affects the localization of VASP protein | CTD | PMID:20164382 |
| folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VASP gene | CTD | PMID:20938992 |
| hemin | multiple interactions | ISO | RGD:1311542 | 6480464 | Hemin inhibits the reaction [Nitroglycerin results in decreased phosphorylation of VASP protein] | CTD | PMID:17541025 |
| L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of VASP gene | CTD | PMID:20938992 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of VASP mRNA | CTD | PMID:21829687 |
| methylmercury chloride | affects expression | EXP | | 6480464 | methylmercuric chloride affects the expression of VASP mRNA | CTD | PMID:21613230 |
| nitroglycerin | multiple interactions | ISO | RGD:1323055 | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [Nitroglycerin results in increased phosphorylation of VASP protein] | CTD | PMID:17868048 |
| nitroglycerin | increases phosphorylation | ISO | RGD:1323055 | 6480464 | Nitroglycerin results in increased phosphorylation of VASP protein | CTD | PMID:17868048 PMID:20129490 |
| nitroglycerin | decreases phosphorylation | ISO | RGD:1311542 | 6480464 | Nitroglycerin results in decreased phosphorylation of VASP protein | CTD | PMID:17541025 PMID:11331261 |
| nitroglycerin | increases phosphorylation | ISO | RGD:1311542 | 6480464 | Nitroglycerin results in increased phosphorylation of VASP protein | CTD | PMID:15331769 PMID:14551241 |
| nitroglycerin | increases phosphorylation | ISO | RGD:1311542 | 6480464 | Nitroglycerin results in increased phosphorylation of VASP protein | CTD | PMID:14551241 PMID:15331769 |
| nitroglycerin | decreases phosphorylation | ISO | RGD:1311542 | 6480464 | Nitroglycerin results in decreased phosphorylation of VASP protein | CTD | PMID:11331261 PMID:17541025 |
| nitroglycerin | multiple interactions | ISO | RGD:1311542 | 6480464 | Hemin inhibits the reaction [Nitroglycerin results in decreased phosphorylation of VASP protein] | CTD | PMID:17541025 |
| nitroglycerin | multiple interactions | ISO | RGD:1311542 | 6480464 | Benomyl inhibits the reaction [Nitroglycerin results in increased phosphorylation of VASP protein] | CTD | PMID:15331769 |
| nitroglycerin | increases phosphorylation | ISO | RGD:1323055 | 6480464 | Nitroglycerin results in increased phosphorylation of VASP protein | CTD | PMID:17868048 |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of VASP mRNA | CTD | PMID:17562736 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of VASP mRNA | CTD | PMID:12595580 |
| pentaerythritol tetranitrate | multiple interactions | ISO | RGD:1311542 | 6480464 | Benomyl inhibits the reaction [Pentaerythritol Tetranitrate results in increased phosphorylation of VASP protein] | CTD | PMID:15331769 |
| pentaerythritol tetranitrate | increases phosphorylation | ISO | RGD:1311542 | 6480464 | Pentaerythritol Tetranitrate results in increased phosphorylation of VASP protein | CTD | PMID:15331769 PMID:17541025 |
| pentaerythritol tetranitrate | increases phosphorylation | ISO | RGD:1311542 | 6480464 | Pentaerythritol Tetranitrate results in increased phosphorylation of VASP protein | CTD | PMID:17541025 PMID:15331769 |
| prostaglandin E1 | increases phosphorylation | ISO | RGD:1323055 | 6480464 | Alprostadil results in increased phosphorylation of VASP protein | CTD | PMID:20129490 |
| prostaglandin E2 | increases phosphorylation | EXP | | 6480464 | Dinoprostone results in increased phosphorylation of VASP protein | CTD | PMID:18182247 |
| resveratrol | increases phosphorylation | ISO | RGD:1323055 | 6480464 | resveratrol results in increased phosphorylation of VASP protein | CTD | PMID:17868048 |
| resveratrol | increases phosphorylation | ISO | RGD:1323055 | 6480464 | resveratrol results in increased phosphorylation of VASP protein | CTD | PMID:17868048 PMID:18716157 |
| resveratrol | decreases expression | ISO | RGD:1323055 | 6480464 | resveratrol results in decreased expression of VASP protein | CTD | PMID:18089832 |
| resveratrol | multiple interactions | ISO | RGD:1311542 | 6480464 | [resveratrol results in increased activity of GSK3B protein] which results in increased phosphorylation of VASP protein | CTD | PMID:19135050 |
| resveratrol | multiple interactions | ISO | RGD:1323055 | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased phosphorylation of VASP protein] | CTD | PMID:17868048 |
| simvastatin | decreases phosphorylation | EXP | | 6480464 | Simvastatin results in decreased phosphorylation of VASP protein | CTD | PMID:19332549 |
| staurosporine | multiple interactions | EXP | | 6480464 | VASP mutant form promotes the reaction [Staurosporine promotes the reaction [CASP3 protein results in increased cleavage of SPNA2 protein]]; more ... | CTD | PMID:18182247 |
| sucrose | multiple interactions | ISO | RGD:1311542 | 6480464 | Chromium inhibits the reaction [Sucrose results in decreased phosphorylation of VASP protein] | CTD | PMID:17215582 |
| sucrose | decreases phosphorylation | ISO | RGD:1311542 | 6480464 | Sucrose results in decreased phosphorylation of VASP protein | CTD | PMID:17215582 |
| tamibarotene | increases expression | ISO | RGD:1323055 | 6480464 | Am 80 results in increased expression of VASP mRNA; more ... | CTD | PMID:15498508 |
| testosterone | multiple interactions | ISO | RGD:1311542 | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of VASP mRNA] | CTD | PMID:20032058 |
| testosterone enanthate | affects expression | ISO | RGD:1323055 | 6480464 | testosterone enanthate affects the expression of VASP mRNA | CTD | PMID:17440010 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:1323055 | 6480464 | resveratrol results in increased phosphorylation of VASP protein | CTD | PMID:17868048 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:1323055 | 6480464 | resveratrol results in increased phosphorylation of VASP protein | CTD | PMID:17868048 PMID:18716157 |
| trans-resveratrol | decreases expression | ISO | RGD:1323055 | 6480464 | resveratrol results in decreased expression of VASP protein | CTD | PMID:18089832 |
| trans-resveratrol | multiple interactions | ISO | RGD:1311542 | 6480464 | [resveratrol results in increased activity of GSK3B protein] which results in increased phosphorylation of VASP protein | CTD | PMID:19135050 |
| trans-resveratrol | multiple interactions | ISO | RGD:1323055 | 6480464 | 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [resveratrol results in increased phosphorylation of VASP protein] | CTD | PMID:17868048 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of VASP mRNA | CTD | PMID:17292431 |
| valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of VASP mRNA | CTD | PMID:22045034 |
| valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of VASP mRNA | CTD | PMID:21427059 |
| vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of VASP mRNA | CTD | PMID:18930951 |